Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
2 Jan 25 | TSHA Taysha Gene Therapies | Common Stock | Grant | Acquire A | No | No | 0 | 324,500 | 0.00 | 1,222,343 |
2 Jan 25 | TSHA Taysha Gene Therapies | Employee Stock Option Common Stock | Grant | Acquire A | No | No | 1.85 | 324,500 | 600.33 k | 324,500 |
11 Jun 24 | SLDB Solid Biosciences | Director Stock Option Common Stock | Grant | Acquire A | No | No | 7.51 | 34,400 | 258.34 k | 34,400 |
2 Jan 24 | TSHA Taysha Gene Therapies | Common Stock | Grant | Acquire A | No | No | 0 | 863,617 | 0.00 | 897,843 |
2 Jan 24 | TSHA Taysha Gene Therapies | Employee Stock Option Common Stock | Grant | Acquire A | No | No | 1.71 | 863,617 | 1.48 mm | 863,617 |
14 Dec 23 | TSHA Taysha Gene Therapies | Employee Stock Option Common Stock | Grant | Acquire A | No | No | 0.6989 | 334,005 | 233.44 k | 334,005 |